Aml3d Ltd · ASX:AL3
Aml3d — Shareholder Meeting (November 2024)
12 slides from Aml3d's shareholder meeting presentation, Nov 8, 2024
Slide 1: Building parts bigger, faster, stronger, and greener
2024 Building parts bigger, faster, Annual General stronger, and greener Meeting AML3D Limited (ASX:AL3) Investor Presentation September 2024 AML3D Limited (ASX:AL3) November 2024
Slide 2: Disclaimer
Disclaimer AML3D Limited (“AML3D” or “the Company”) does not take The recipient should not rely on any material contained in this responsibility for any information, statement or representation presentation as a statement or representation of fact. No recipient should contained in this presentation
Slide 3: Board: Broad experience – Global skillsets
Board: Broad experience – Global skillsets Noel Cornish AM Sean Ebert Andy Sales Katilin Smith Chairman, Non-Executive Director Managing Director Executive Director, CTO Peter Siebels Company Secretary B.Sc, M.Eng.Sc., FAICD FUOW BEng Hons(Electrical), GAICD, MBA Non-Executive Director MEng, MSc, CE
Slide 4: Agenda
Agenda Building parts bigger, faster, stronger, 01 Chairman’s Addressand greener Noel Cornish AM Chairman Sean Ebert 02 CEO and MD’s Address Non-Executive Director Noel Cornish AM 03 Formal Business Chairman AML3D Limited (ASX:AL3) Investor Presentation September 2024
Slide 5: Chairman's Address
Chairman’s Address 10-fold increase in revenue driven by US scale up strategy and reinforced by establishing AML3D’s US manufacturing. Investing to support medium and longer-term growth, transform metal manufacturing and access new markets. Strong balance sheet with stable, experienced leadership wi
Slide 6: CEO and MD's Address: Summary
CEO and MD’s Address: Summary Success of growth strategy moves AML3D from being a ‘seller of 3D printed parts’ to a ‘seller of 3D printing systems and parts.’ Huge demand in the US, the world’s largest advanced additive manufacturing market, valued at US$2.6 billion in 2023 and growing. Strong relat
Slide 7: CEO and MD's Address: Financial Performance
CEO and MD’s Address: Financial Performance ARCEMY® Diverse revenue drivers across ARCEMY® system sales system sales, component manufacturing and $4.44m testing and license and lease fees. ↑ 61% Parts testing and Strong US demand translates into a manufacture contracted pipeline of $7.42 million of
Slide 8: CEO and MD's Address: US Scale Up Strategy
CEO and MD’s Address: US Scale Up Strategy Building on 1st ARCEMY® sale to US Navy center of excellence at the Oak Ridge Laboratories in Tennessee in Feb. 2023. Leveraging direct sales teams and Phillips value add reseller relationship to rapidly grow US sales capability and footprint. Established p
Slide 9: CEO and MD's Address: US Manufacturing Hub
CEO and MD’s Address: US Manufacturing Hub Modern, purpose-built manufacturing hub in Stow, Ohio, means highly responsive to US customer’s needs. US based manufacturing hub creates a potential pathway to securing, high value, ITAR Defence contracts ARCEMY® supports sovereign manufacturing and addres
Slide 10: CEO and MD's Address: Outlook
CEO and MD’s Address: Outlook US and Asia pacific growth accelerating with strong order pipeline and key manufacturing license agreements in place. Strong demand signals support the next phase of the growth – expansion in additional globally significant defence markets. Over $7 million of revenue al
Slide 11: Thank You
2024 Building parts bigger, faster, Meeting stronger,Close and greener Thank You AML3D Limited (ASX:AL3) Investor Presentation September 2024
Slide 12: Contact
Address Building parts bigger, faster, Unit 4, 136 Mooringe Ave, North Plympton SA stronger, and greener Contact Sean Ebert Hamish McEwin Managing Director Chief Financial Officer T: +61 8 8258 2658 T: +61 8 8258 2658 E:AML3D investor@aml3d.com Limited (ASX:AL3) E: investor@aml3d.com Investor Presen